Yahoo Web Search

Search results

    • Image courtesy of highlighttherapeutics.com

      highlighttherapeutics.com

      • Because of how quickly the infection spreads, the immune system gets overwhelmed and becomes dysregulated – meaning it stops functioning as it normally should. This triggers an exaggerated immune response known as a cytokine storm.
      theconversation.com › sepsis-why-this-deadly-condition-is-so-hard-to-diagnose-231120
  1. People also ask

  2. 20 hours ago · Sepsis is a severe condition that arises when the body’s response to an infection injures its own tissues and organs. It can develop in a very short timeframe – usually hours, if untreated. Sepsis is typically triggered by a bacterial or viral infection – often in the lungs, urinary tract, abdomen or from a wound.

  3. Jun 4, 2024 · There are numerous reasons why sepsis is such a dangerous condition. This largely comes down to how difficult it is to diagnose. Early sepsis symptoms tend to share similarities with many other illnesses. Often, patients start out with flu-like symptoms - such as fever, rapid breathing and increased heart rate.

  4. 20 hours ago · Lung infection in the neutropenic patient. Its not that noninvasive mechanical ventilation enhances the survival of immunocompromised patients; rather, invasive ventilation seems to be associated with a poorer outcome, perhaps because of the increased risk of nosocomial pneumonia and poorer secretion clearance.

  5. 20 hours ago · According to Arturo Casadevall, M.D., Ph.D., the term "pathogen"-generally defined as a microbe that causes disease-should be relegated to the archives of scientific lexicon. "The central problem is that when you call a microbe a pathogen, you're giving it a trait that is not its own, for no microbe can be a pathogen without a host," he said ...

  6. 20 hours ago · Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today released positive Phase 1/2 pivotal study results for the investigational PRGN-2012 off-the-shelf (OTS) AdenoVerse® gene therapy in patients with recurrent respiratory papillomatosis (RRP). Results were presented in a late ...